APA

Weeden C. E., Holik A. Z., Young R. J., Ma S. B., Garnier J., Fox S. B., Antippa P., Irving L. B., Steinfort D. P., Wright G. M., Russell P. A., Ritchie M. E., Burns C. J., Solomon B. & Asselin-Labat M. (20180626). Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma. : Molecular cancer therapeutics.

Chicago

Weeden Clare E, Holik Aliaksei Z, Young Richard J, Ma Stephen B, Garnier Jean-Marc, Fox Stephen B, Antippa Phillip, Irving Louis B, Steinfort Daniel P, Wright Gavin M, Russell Prudence A, Ritchie Matthew E, Burns Christopher J, Solomon Benjamin and Asselin-Labat Marie-Liesse. 20180626. Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma. : Molecular cancer therapeutics.

Harvard

Weeden C. E., Holik A. Z., Young R. J., Ma S. B., Garnier J., Fox S. B., Antippa P., Irving L. B., Steinfort D. P., Wright G. M., Russell P. A., Ritchie M. E., Burns C. J., Solomon B. and Asselin-Labat M. (20180626). Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma. : Molecular cancer therapeutics.

MLA

Weeden Clare E, Holik Aliaksei Z, Young Richard J, Ma Stephen B, Garnier Jean-Marc, Fox Stephen B, Antippa Phillip, Irving Louis B, Steinfort Daniel P, Wright Gavin M, Russell Prudence A, Ritchie Matthew E, Burns Christopher J, Solomon Benjamin and Asselin-Labat Marie-Liesse. Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma. : Molecular cancer therapeutics. 20180626.